Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

219 Views

Poster Session: Respiratory Infections - Viral

2207 - Rates of Lower Respiratory Tract Infections Among US Adults Aged ≥18 Years With and Without Chronic Medical Conditions

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Co-Author(s)

DW

Derek Weycker, Ph.D.

Senior Health Economist
Policy Analysis Inc.
Chestnut Hill, Massachusetts, United States
AA

Ahuva Averin, M.P.P.

Policy Analysis Inc.
Chestnut Hill, Massachusetts, United States
LH

Linnea Houde, M.S.

Policy Analysis Inc.
Chestnut Hill, Massachusetts, United States
KO

Kevin Ottino, M.H.S.

Policy Analysis Inc.
Chestnut Hill, Massachusetts, United States
KS

Kimberly M. Shea, Ph.D., M.P.H.

Value and Evidence Lead
Pfizer Inc.
Newton, Massachusetts, United States
BG

Bradford J. Gessner, M.D., M.P.H.

Vice President Global Medical Lead for Respiratory Vaccines
Pfizer Biopharma Group
Collegeville, Pennsylvania, United States

Presenting Author(s)

KY

Kari Yacisin, M.D.

Senior Director, U.S. Medical Affairs
Pfizer Inc.
Collegeville, Pennsylvania, United States

Co-Author(s)

DC

Daniel Curcio, M.Sc.

Pipeline Vaccine Expert Emerging Markets, Pfizer, Argentina.
Pfizer Inc.
Buenos Aires, Buenos Aires, Argentina
EB

Elizabeth Begier, M.D., M.P.H.

Pfizer Vaccines
Dublin, Dublin, Ireland
MR

Mark Rozenbaum, Ph.D., M.B.A.

Pfizer Inc.
Randstad, Noord-Holland, Netherlands